This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
07 Dec 2020
MAHSC Seminar Series: ‘Understanding and treating suicidality: Pre and during COVID-19’
Manchester Academic Health Science Centre (MAHSC), part of Health Innovation Manchester, brings together world leading academic and NHS partners to drive health research forward.
The MAHSC Seminar Series will showcase the great discovery and clinical science being undertaken within Manchester and its impact on the health of the local population.
The series will give a local platform to the nationally and internationally renowned scientists of MAHSC, to share their work with clinical, non-clinical and university colleagues but also crucially members of the wider community seeking insight into innovations in the delivery of healthcare.
In the eight and final seminar of the year, held on 2 December 2020, our speakers discuss suicide before and during COVID-19, understanding its effects and treating the illness. We were joined by Professor Gillian Haddock, Professor Roger Webb, Dr Yvonne Awenat, Dr Daniel Pratt and Dr Trish Gooding.
Peter Clayton, Chief Academic Officer at Health Innovation Manchester chaired this session. He welcomed guests to the webinar and said: “This is the eighth seminar in our series, we started the seminars in the summer so that we could showcase the great discoveries and clinical science that’s being undertaken within Manchester and within the Academic Health Science Centre and the impact that it has on the health of the local population and beyond. There has been a significant focus on COVID-related research and this afternoon is no exception.”
Watch the session
Watch the session to see what our line-up of speakers discussed.
‘Understanding and treating suicidality: Pre and during COVID-19’.